Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Glaxosmithkline Pharmaceuticals LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500660NSE Symbol: GLAXOP/E(TTM):56.55
ISIN Demat:INE159A01016Div & Yield %:1.4EPS(TTM):40.52
Book Value(Rs):105.3141964Market Cap ( Cr.):38820.24Face Value(Rs):10
    Change Company 
( In Cr)
ParticularsMar 2024Dec 2023Sep 2023Jun 2023
 Rs CrRs CrRs CrRs Cr
Gross Sales 910.87804.98953.38738.02
Other Operating Income 0.000.000.000.00
Other Income  32.2728.3428.4754.10
Total Income 943.14833.32981.85792.12
Total Expenditure  655.56750.78666.80596.77
PBIDT 287.5882.54315.05195.35
Interest  0.770.320.430.28
PBDT 286.8182.22314.62195.07
Depreciation 18.1017.1118.1116.36
Tax 61.1631.3290.6052.63
Fringe Benefit Tax 0.000.000.000.00
Deferred Tax 14.47-11.70-9.63-4.50
Reported Profit After Tax 193.0845.49215.54130.58
Extra-ordinary Items  1.72-131.990.0012.21
Adjusted Profit After Extra-ordinary item 191.36177.48215.54118.37
     
EPS (Unit Curr.) 11.292.6912.726.94
EPS (Adj) (Unit Curr.) 11.292.6912.726.94
Calculated EPS (Unit Curr.) 11.402.6912.727.71
Calculated EPS (Adj) (Unit Curr.) 11.402.6912.727.71
Calculated EPS (Ann.) (Unit Curr.) 45.5910.7450.8930.83
Calculated EPS (Adj) (Ann.) (Unit Curr.) 45.5910.7450.8930.83
Book Value (Unit Curr.) 0.000.000.000.00
Dividend (%) 0.000.00320.000.00
Equity 169.41169.41169.41169.41
Reserve & Surplus 0.000.000.000.00
Face Value 10.0010.0010.0010.00
     
Public Shareholding (No Of.Shares) 0.000.000.000.00
Public Shareholding (% in Equity) 0.000.000.000.00
     
Pledged/Encumbered - No. of Shares 0.000.000.000.00
Pledged/Encumbered - % in Total Promoters Holding 0.000.000.000.00
Pledged/Encumbered - % in Total Equity 0.000.000.000.00
     
Non Encumbered - No. of Shares 0.000.000.000.00
Non Encumbered - % in Total Promoters Holding 0.000.000.000.00
Non Encumbered - % in Total Equity 0.000.000.000.00
     
PBIDTM(%) 31.5710.2533.0526.47
PBDTM(%) 31.4910.2133.0026.43
PATM(%) 21.205.6522.6117.69